The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identification of pathogenic ROS1 alterations in cell-free DNA (cfDNA) from patients with breast cancer.
 
Jeremy Meyer Force
Consulting or Advisory Role - Myriad Genetics; NanoString Technologies; Pfizer
Speakers' Bureau - Genomic Health
 
Mary Love Taylor
No Relationships to Disclose
 
Leylah Drusbosky
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Travel, Accommodations, Expenses - Guardant Health
 
Jennifer Yen
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Paul Kelly Marcom
Consulting or Advisory Role - Celltrion; Genentech/Roche; Immunomedics; Merck; Novartis
Speakers' Bureau - Catamount Medical Education; Clinical Care Options
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Genentech/Roche (Inst); Glycomimetics (Inst); Innocrin Pharma (Inst); Novartis (Inst); Verily (Inst)
 
Carey K. Anders
Honoraria - Eisai; Genentech/Roche; IPSEN; Puma Biotechnology; Seagen
Consulting or Advisory Role - Eisai; Genentech/Roche; Ipsen; Puma Biotechnology; Seagen
Research Funding - G1 Therapeutics (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Puma Biotechnology (Inst); Seagen (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Jones and Bartlett; Up to Date.com
Travel, Accommodations, Expenses - Eisai
 
Jeffrey R Marks
No Relationships to Disclose